ArticleTranslational psychiatry2026
A combined study of whole-exome sequencing and structural neuroimaging markers in bipolar disorder.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bipolar disorder (BD) is a highly heritable psychiatric disorder. An increasing number of whole-exome sequencing (WES) studies have been conducted on psychiatric research. However, few studies have investigated the association between single nucleotide variants (SNVs) in WES and structural brain changes in patients with BD. We conducted WES on 93 patients with BD and 161 healthy controls (HCs) to detect germline variants and copy number alterations (CNAs), as well as the gene-based effects of rare variants on BD. The impact of genetic factors on structural neuroimaging markers, including cortical thickness and white matter tract integrity, was examined using neuroimaging-genetic association analysis. We identified 382 BD-related genes, including SYNE1, PKHD1L1, FRAS1, and ZFHX4, from a systematic review, and the most frequently mutated genes. We identified a new gene, GNB3, which harbors a significant burden of rare nonsynonymous variants that affect BD. By integrating WES and structural neuroimaging data, we found that the single nucleotide polymorphism (SNP) rs56850341 in KMT2C was substantially correlated with structural neuroimaging measures, including cortical thickness and white matter tract integrity. In the present study, we suggest that rare nonsynonymous variants in GNB3 may be involved in the pathophysiology of BD, and that highly contributing heritable genetic variant in KMT2C may influence brain structural changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.